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Abstract
Background: Temporomandibular joint disorders (TMJD) are multifactor, complex clinical problems
affecting approximately 60–70% of the general population, with considerable controversy about the most
effective treatment. For example, reports claim success rates of 70% and 83% for non-surgical and surgical
treatment, whereas other reports claim success rates of 40% to 70% for self-improvement without
treatment. Therefore, the purpose of this study was to (1) identify systematic reviews comparing
temporomandibular joint disorder surgical and non-surgical treatment, (2) evaluate their methodological
quality, and (3) evaluate the evidence grade within the systematic reviews.
Methods: A search strategy was developed and implemented for MEDLINE, Cochrane Library, LILACS,
and Brazilian Dentistry Bibliography databases. Inclusion criteria were: systematic reviews (± meta-
analysis) comparing surgical and non-surgical TMJD treatment, published in English, Spanish, Portuguese,
Italian, or German between the years 1966 and 2007(up to July). Exclusion criteria were: in vitro or animal
studies; narrative reviews or editorials or editorial letters; and articles published in other languages. Two
investigators independently selected and evaluated systematic reviews. Three different instruments
(AMSTAR, OQAQ and CASP) were used to evaluate methodological quality, and the results averaged.
The GRADE instrument was used to evaluate the evidence grade within the reviews.
Results: The search strategy identified 211 reports; of which 2 were systematic reviews meeting inclusion
criteria. The first review met 23.5 ± 6.0% and the second met 77.5 ± 12.8% of the methodological quality
criteria (mean ± sd). In these systematic reviews between 9 and 15% of the trials were graded as high
quality, and 2 and 8% of the total number of patients were involved in these studies.
Conclusion: The results indicate that in spite of the widespread impact of TMJD, and the multitude of
potential interventions, clinicians have expended sparse attention to systematically implementing clinical
trial methodology that would improve validity and reliability of outcome measures. With some 20 years
of knowledge of evidence-based healthcare, the meager attention to these issues begins to raise ethical
issues about TMJD trial conduct and clinical care.
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Background
Temporomandibular Joint Disorders (TMJD) is a collec-
tive term used to describe a number signs and symptoms
involving the temporomandibular joints, masticatory
muscles, and associated structures. Approximately 60–
70% of the general population has at least one sign of a
temporomandibular disorder which include limited
mouth opening, clicking, and locking (e.g.: [1,2]). Fur-
ther, TMJD is frequently associated with pain in regions
outside of the immediate joint area, such as recurrent
headaches and neck pain[1,3]. Patients afflicted with a
severe TMJD can experience significant reductions in qual-
ity of life, affecting both personal life and work, and eve-
ryday activities such as eating, talking, yawning, and
laughing can become painful [1-3].
The treatment of TMJD can be divided into two main
groups. The first is the non-surgical therapy and it
includes treatments such as counselling, physiotherapy,
pharmacotherapy, and occlusal splint therapy (e.g.:[1,4]).
The other is the surgical therapy and it ranges from tem-
poromandibular joint arthrocentesis and arthroscopy to
the more complex open joint surgical procedures, referred
to as arthrotomy (e.g.:[5]). Narrative reviews indicate that
the success rate of nonsurgical treatment is approximately
70% (e.g.:[1]) and the surgical treatment success is
approximately 83% (e.g.:[5]), whereas other studies
report approximately 40% to 70% self-improvement
without any treatments (e.g.:[6,7]). Systematic reviews,
however, paint a different picture. The systematic reviews
indicate that there is not enough high quality evidence to
make informed clinical decisions (e.g.: [8-17]). Yet, some
systematic reviews do offer treatment guidance. Clearly,
there is some controversy about which treatments are the
most effective.
To provide a baseline of high quality information, Bader
and Ismail [18] performed a literature survey identifying
published systematic reviews of on clinical dentistry, of
which 7 examined TMJD. Two addressed the cause and
effect of TMJD, one study addressed diagnosis and imag-
ing techniques, and the remaining 4 reviews were about
the treatment of TMJD. None addressed TMJD surgical
treatment.
The purpose of the current study, therefore, was to (1)
identify systematic reviews comparing temporomandibu-
lar joint disorder surgical and non-surgical treatment, (2)
evaluate their methodological quality, and (3) evaluate
the evidence grade within the systematic reviews.
Methods
A search strategy (Table 1) was developed to identify sys-
tematic reviews (SR) that address TMJD treatment. The
search comprised articles indexed in MEDLINE, Cochrane
Library, LILACS, and Brazilian Dentistry Bibliography
databases that were published in English, Spanish, Portu-
guese, Italian, and German between the years 1966 and
2007 (up to July, 31).
The following inclusion criteria were used to identify
potentially relevant papers: the article was really a system-
atic review or meta-analysis, as stated and described in
methods section of the publication, and the primary focus
was a comparison among different TMJD surgical treat-
ments and non-surgical treatment. Exclusion criteria were:
systematic reviews addressing non-surgical TMJD only;
clinical trials, narrative reviews or editorials or letters to
editor; in vitro or animal studies; articles published in lan-
guages other than English, Spanish, Portuguese, Italian or
German. Initially, two investigators (RVBN and RN) inde-
pendently read all the titles and abstracts from the multi-
ple search results to identify potentially eligible articles for
inclusion. All potentially eligible studies were then
retrieved and full-text article was reviewed to determine if
it met the inclusion criteria. Disagreements were resolved
by discussion among the investigators.
In the next phase, the investigators independently evalu-
ated the identified systematic reviews using three instru-
ments (AMSTAR, OQAQ and CASP) to appraise the
methodological quality of systematic review [19-21].
AMSTAR[19] or 'Assessment of Multiple Systematic
Reviews' consists of 11 items tool and was developed
Table 1: Search Strategy
MEDLINE, Cochrane Library, LILACS, and Brazilian Dentistry Bibliography between the years 1966 and 2007 (up to July, 31)
Review
OR
Review Literature
OR
Meta-Analysis
AND Temporomandibular Joint/surgery
OR
Temporomandibular Joint Disk/surgery
OR
Craniomandibular Disorders/surgery
OR
Temporomandibular Joint Disorders/surgery
OR
Temporomandibular Joint Dysfunction Syndrome/surgeryBMC Oral Health 2008, 8:27 http://www.biomedcentral.com/1472-6831/8/27
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pragmatically using previously published tools and expert
consensus. The original 37 items were reduced to an 11
item instrument addressing key domains (eg. study ques-
tion, search strategy, inclusion/exclusion criteria, data
extraction, study quality). The resulting instrument was
judged by the expert panel to have face and content valid-
ity[19] and The Canadian Agency for Drugs and Technol-
ogies in Health (CADTH) was selected AMSTAR as the
best instrument for appraising systematic reviews[22,23].
OQAQ[20] or 'Overview Quality Assessment Question-
naire' has nine individual items and it specified purpose is
to evaluate the scientific quality (i.e., adherence to scien-
tific principles) of systematic reviews published in medi-
cal literature. This scale is not designed to measure literary
quality or importance. The validity of the scale has been
tested and validated[20].
The Critical Appraisal Skills Programme or CASP was
developed by the Public Health team in Oxford[24] and
the programme of North Thames Research Appraisal
Group (NTRAG). It aims to enable clinicians to develop
the skills to find and make sense of research evidence,
helping them to put knowledge into practice. CASP uses
an instrument to appraise systematic reviews based on 10
questions[21]. These questions address key domains (eg.
comprehensive search, validity assessment, results combi-
nation) of methodological quality.
To have a standard way to compare, the answers of each
instrument were scored 'yes' or 'no' when the criterion was
explicitly met or not met, and 'can't tell' if methods were
reported incompletely or not reported at all. For the calcu-
lation of the overall methodological quality the mean of
the number of 'yes', 'can't tell', 'no' answers recorded for
each instrument were determined.
To appraise the quality of the underlying evidence, we
used the GRADE system [25,26]. Essentially GRADE clas-
sifies quality in four categories: randomized clinical trials
(RCT) that show consistent results (high quality); rand-
omized clinical trials with methodological limitations or
QUASI-RCT (moderate quality); and observational stud-
ies with control groups (e.g., cohort and case-control stud-
ies) without exceptional strengths (low quality);
unsystematic clinical observations (e.g., case reports and
case series) as evidence of very low quality evidence (very
low quality).
The number of reports that met each of the criteria was
determined and tabulated. The estimated mean overall
quality score was calculated using Excel for windows
(Microsoft, USA) spreadsheets.
Results
Search results
Figure 1 summarizes the results of the Medline, Cochrane
Library, LiLACS and Brazilian Dentistry Bibliography
databases searches. 211 references that appeared to meet
the definition of systematic review or meta-analysis were
identified (Additional file 1). Inspection of the titles and
abstracts by two investigators excluded 97 as not meeting
inclusion criteria, leaving 114 that appeared to be relevant
or which abstracts were missing. Full text of the 114 refer-
ences was obtained and their reference lists examined for
additional relevant articles. Of the 114, 112 were elimi-
nated leaving 2 articles that met all inclusion criteria.
The included systematic reviews are summarized in Table
2. The first systematic review, Kropmans et al [27]
addressed the question: what are the positive effects of
arthroscopic surgery, arthrocentesis and physical therapy
with regard to TMJD. The second, Reston and Turkelson
[28], addressed the question: can any surgical procedures,
compared to non-surgical therapy effectively treat TMJD?
The quality of the systematic reviews and overall quality of 
the evidence
The evaluation of the methodological quality of the
included reviews for each instrument is shown in Tables
3. 4, 5, 6, 7, 8 and the overall quality results are shown in
Table 9. The Kropmans et al review[27] met 23.5 ± 6.0%
(ranging 18.2% to 30% 'yes' answers) and the Reston and
Turkelson review[28] met 77.5 ± 12.8% (ranging 63.6 to
88.9% yes answers) of the methodological quality criteria
(mean ± sd).
Table 10 summarizes the quality of evidence in each
review. Data from 20 articles (4585 patients) were ana-
lyzed by Kropmans et al[27]. Data from 23 articles (1463
patients) were analyzed by Reston and Turkelson[28].
Only three (15%) articles in Kropmans et al[27] review
were randomized clinical trials (high quality evidence),
which represents 1.6% of the number of patients and six
(30%) were Quasi-RCT (moderate evidence), represent-
ing 6% of the patients. In this case, methodological qual-
ity varied between RCTs in terms of how the sequence
generation was done and the adequacy of allocation con-
cealment. Conversely, eleven (55%) of the articles were
non-systematic clinical observations (ie, case reports and
case series), which were classified as very-low-quality evi-
dence and represents 92.3% of the number of patients.
The analysis of the included articles in Reston and Turkel-
son[28] showed that two (8.7%) were randomized clini-
cal trials, which represents 7.7% of the number of
patients, five (21.7%) were observational studies (low evi-
dence), which represents 29% of the patients, and 16
(69.6%) were case series, which represents 63.3% of the
number of patients.BMC Oral Health 2008, 8:27 http://www.biomedcentral.com/1472-6831/8/27
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Discussion
In this report, we sought to identify and evaluate the qual-
ity of systematic reviews comparing surgical and non-sur-
gical care of TMJD. Our search strategy identified two
reviews (one with and one without a meta-analysis).
Kropmans et al[27] found no difference in clinical out-
comes (e.g.: maximal mouth opening, pain, or function
improvement) when comparing arthroscopic surgery,
arthrocentesis, and physical therapy. Similarly, Reston
and Turkelson[28] examining the efficacy of the surgical
techniques arthrocentesis, arthroscopy, and disc repair/
reposition, found no difference in clinical outcomes. Con-
ceptually, both studies provide estimates of surgical vs.
surgical and non surgical care, and both indicate that
there are no significant differences between the interven-
tions examined (Table 2). However, the methodological
quality (from 0 to 100, with 100 being the best) of these
two systematic reviews (Kropmans et al[27] = 23.5; Res-
ton and Turkelson[28] = 77.5), and the underlying high
quality evidence upon which they are based (from 0 to
100, with 100 being the best) (Kropmans et al[27] = 15;
Reston and Turkelson[28] = 8.7), suggests that the inter-
pretations of these authors may be over- (or under-) state-
ments. This leads one to an interesting dilemma: How can
one best care for patients if there are few high quality stud-
ies upon which to base this care?
The authors of the systematic reviews recognized some of
these shortcomings. Reston and Turkelson[28] pointed
out that their study is an explicit attempt to provide a con-
clusion when reliable primary data are not available and
recognized that clinical and policy decisions must often
be made in the absence of well-designed trials. They also
discussed two main flaws. The first is that there are few
studies that evaluated a specific treatment on specific
TMJD sub-groups of patients; therefore the relative effi-
cacy of each treatment could not be defined. The other is
that the studies contained a wide range of definitions of
success or improvement after treatment. Kropmans et
al[27] reported that none of the reviewed scientific papers
Flow chart showing the results of the search strategy Figure 1
Flow chart showing the results of the search strategy.
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reported the measurement error of the procedures used
(e.g.: standard error of measurement or 95% confidence
interval).
Another set of issues is the classification of trials design.
There are 8 articles common to both reviews, from which
3 match the same study design classification and 5 don't
match. This could be explained by differences in the way
that the included systematic reviews classified the study
design of each article. A possible solution to this problem
is the use of standard approaches to classify study designs,
thus providing more consistency (e.g.:[29]). These
approaches has been used successfully by other areas of
dental care (e.g.: preventive dentistry[30,31]).
Table 2: Summary of the included systematic reviews
Year of Publication Authors Included Surgical 
Procedures
Specific Outcome Conclusion
1999 Kropmans et al 
[27]
Arthroscopic 
surgery
Arthrocentesis
All studies claimed effectiveness of the therapeutic 
intervention(s). 11 (35%) of the studies compared different 
sets of therapeutic interventions but none of them found a 
statistical significant difference between the effects of 
different interventions.
No differences in 
effects on MMO and 
pain intensity or 
mandibular function 
impairment were 
found between 
arthroscopic surgery, 
arthrocentesis and 
physical therapy.
2003 Reston and 
Turkelson [28]
Arthrocentesis
Arthroscopy
Disc repair/
reposition
Arthroscopy vs 
Arthrocentesis (1)
0.08 (95% CI: – 1.05 to 
1.21) p = 0.446548 (2)
0.21 (95% CI: – 0.35 to 
0.77) p = 0.230041 (3)
0.22 (95% CI: – 0.36 to 
0.79) p = 0.231138 (4)
There were no 
statistically significant 
differences in the 
outcomes of patients 
given these different 
treatments regardless 
of the improvement 
rate we assumed for 
the control group.
Arthroscopy vs Disc repair/
reposition (1)
- 0.75 (95% CI: – 2.02 to 
0.52) p = 0.123673 (2)
- 0.47 (95% CI: – 1.00 to 
0.06) p = 0.042119 (3)
- 0.47 (95% CI: – 1.02 to 
0.09) p = 0.050217 (4)
Arthrocentesis vs Disc 
repair/reposition (1)
- 0.83 (95% CI: – 2.35 to 
0.70) p = 0.144515 (2)
- 0.68 (95% CI: – 1.40 to 
0.04) p = 0.032832 (3)
- 0.68 (95% CI: – 1.43 to 
0.07) p = 0.037370 (4)
(1) Differences Between Subgroup Means
(2) Assumptions of 0% improvement in the absence of treatment
(3) Assumptions of 37.5% improvement in the absence of treatment
(4) Assumptions of 75% improvement in the absence of treatment
Table 3: AMSTAR component score results for Kropmans et al 1999[27]
AMSTAR Question YES Can't Tell No
1. Was an 'a priori' design provided? X
2. Was there duplicate study selection and data extraction? X
3. Was a comprehensive literature search performed? X
4. Was the status of publication (i.e. grey literature) used as an inclusion criterion? X
5. Was a list of studies (included and excluded) provided? X
6. Were the characteristics of the included studies provided? X
7. Was the scientific quality of the included studies assessed and documented? X
8. Was the scientific quality of the included studies used appropriately in formulating conclusions? X
9. Were the methods used to combine the findings of studies appropriate? X
10. Was the likelihood of publication bias assessed? X
11. Was the conflict of interest stated? XBMC Oral Health 2008, 8:27 http://www.biomedcentral.com/1472-6831/8/27
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While the overall quality of the reviews is of some interest,
the results of each measurement tool (Tables 3, 4, 5, 6, 7,
8) may offer additional insight into areas that could be
improved. For example, the common missing elements in
systematic reviews, in general, are: explicit search strategy;
explicit articulation of exclusion criteria; absence of qual-
ity assessment of the underlying studies; and inappropri-
ate aggregation of study results[32]. Thus, there are crucial
elements in the conduct of a systematic review, without
which the results may be questionable. From the analysis
of Tables 3, 4, 5, 6, 7, 8 one can identify that each included
systematic review showed different results for each instru-
ment. This could be explained by the fact that each instru-
ment has a question pattern to appraise methodological
quality and address different key areas. For example,
AMSTAR addresses to potential bias in systematic reviews
(such as: funding source and conflict of interest) that
OQAQ and CASP doesn't.
Ideally, systematic reviews should be the starting point for
any search for information[33]. The results of the current
study raise questions about the quality of the systematic
reviews and clinical trials upon which TMJD care is based.
Unfortunately, this is a long standing systematic problem.
A systematic review of TMJD diagnosis[34], which was
carried out more than 10 years ago, reported major to
extensive methodologic flaws in 40% of the analyzed
studies. Similarly, in examining the clinical literature,
Bader and Ismail[18] identified 7 systematic reviews on
diagnosis and non-surgical treatment of TMJD. For 6 of
the reviews (85.7%) they identified a need for well
designed controlled studies, the use of standardized diag-
nostic criteria and outcome measures. Finally a 2007
report from the United States Government Accountability
Office[35] examined the Food and Drug Administration
agency approval for the use of temporomandibular joint
implants. They identified some of the same methodolog-
ical problems: inadequate or inaccurate measurements,
sample size and patient follow-up.
Thus, many of the previous results and this systematic
review are congruent. That is, clinical scientists need to
begin designing, implementing, and reporting clinical tri-
als and systematic reviews that meet international stand-
ards[36]. In terms of international standards and chronic
pain, there is the IMMPACT[37] recommendations, which
suggest that chronic pain clinical trials should assess out-
comes representing six core domains: (1) pain, (2) physi-
cal functioning, (3) emotional functioning, (4)
participant ratings of improvement and satisfaction with
treatment, (5) symptoms and adverse events, (6) partici-
pant disposition (e.g. adherence to the treatment regimen
and reasons for premature withdrawal from the trial).
More specifically, for TMJD, a coalescence of symptom
and outcome measurements could be profound. For
Table 4: OQAQ component score results for Kropmans et al 1999[27]
OQAQ Question YES Can't Tell No
1. Were the Search methods used to find evidence on the primary question(s) stated? X
2. Was the search for evidence reasonably comprehensive? X
3. Were the criteria used for deciding which studies to include in the overview reported? X
4. Was bias in the selection of studies avoided? X
5. Were the criteria used for assessing the validity of the included studies reported? X
6. Was the validity of all the studies referred to in the text assessed using appropriate criteria? X
7. Were the methods used to combine the findings of the relevant (to reach a conclusion) reported? X
8. Were the findings of the relevant studies combined appropriately relative to the primary question of the overview? X
9. Were the conclusions made by the author(s) supported by the data and/or analysis reported in the overview? X
Table 5: CASP component score results for Kropmans et al 1999[27]
CASP Question YES Can't Tell No
1. Did the review ask a clearly-focused question? X
2. Did the review include the right type of study? X
3. Did the reviewers try to identify all relevant studies? X
4. Did the reviewers assess the quality of the included studies? X
5. If the results of the studies have been combined, was it reasonable to do so? X
6. The main results are presented? X
7. Are these results precise? X
8. Can the results be applied to the local population? X
9. Were all important outcomes considered? X
10. Should policy or practice change as a result of the evidence contained in this review? XBMC Oral Health 2008, 8:27 http://www.biomedcentral.com/1472-6831/8/27
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example, one might consider measurements and report-
ing of pain as pioneered by the Oxford Pain Research
Center[38]. This Pain Center, in generating or evaluating
systematic reviews of acute pain, prefers validated visual
analog scales (VAS) to report pain, specifically includes
randomised, double-blind, single-dose studies in patients
with moderate to severe pain, and looks for outcomes of
50% pain relief at 4–6 hours. The analog for TMJD could
be VAS of symptoms pre-therapy and 3-months post-ther-
apy. Post-therapy reporting would include both the
number and percentage of patients with 50% pain relief
for both the experimental and control group.
This would, however, necessitate having clinical scientists
register their trials, select and implement interventions
and comparisons in a standard, randomized, blinded
fashion, and completely report these results using the
CONSORT guideline (e.g.:[39]). Were this to occur it
would substantially improve the evidence-base, reduce
the variation in care and improve knowledge of patient
outcomes. Moreover, there are also guidelines (e.g.:
TREND[40]) to help researchers improve the transparency
or clarity of non-randomized designs reports.
There are at least four limitations to our study. First, sev-
eral instruments exist to assess the methodological quality
of systematic reviews[41], but not all of them have been
developed systematically or empirically validated and
have achieved general acceptance[19]. Furthermore, since
their development, considerable empirical research has
accumulated about potential sources of bias in systematic
reviews. For example, recent methodological research has
highlighted the potential importance of publication lan-
guage and publication bias in systematic reviews[19]. As
an attempt to address the slightly varying perspectives of
these instruments, we averaged the outcomes of each
instruments. Moreover, the average of the group of does
not differ radically from the assessment of any individual
instrument. This suggests that the average is a reasonable
estimate of the quality.
Second, our searches identified 211 studies, of which 22
(10.4%) were in excluded languages. Thus, while we
attempted to capture the majority of the published litera-
ture, we clearly missed a significant portion of the litera-
ture. Third, we did not examine the reference lists of the
identified articles, further increasing the probability of
missed information. Forth, to extrapolate our results to
Table 6: AMSTAR component score results for Reston and Turkelson 2003[28]
AMSTAR Question YES Can't Tell No
1. Was an 'a priori' design provided? X
2. Was there duplicate study selection and data extraction? X
3. Was a comprehensive literature search performed? X
4. Was the status of publication (i.e. grey literature) used as an inclusion criterion? X
5. Was a list of studies (included and excluded) provided? X
6. Were the characteristics of the included studies provided? X
7. Was the scientific quality of the included studies assessed and documented? X
8. Was the scientific quality of the included studies used appropriately in formulating conclusions? X
9. Were the methods used to combine the findings of studies appropriate? X
10. Was the likelihood of publication bias assessed? X
11. Was the conflict of interest stated? X
Table 7: OQAQ component score results for Reston and Turkelson 2003[28]
OQAQ Question YES Can't Tell No
1. Were the Search methods used to find evidence on the primary question(s) stated? X
2. Was the search for evidence reasonably comprehensive? X
3. Were the criteria used for deciding which studies to include in the overview reported? X
4. Was bias in the selection of studies avoided? X
5. Were the criteria used for assessing the validity of the included studies reported? X
6. Was the validity of all the studies referred to in the text assessed using appropriate criteria? X
7. Were the methods used to combine the findings of the relevant (to reach a conclusion) reported? X
8. Were the findings of the relevant studies combined appropriately relative to the primary question of the overview? X
9. Were the conclusions made by the author(s) supported by the data and/or analysis reported in the overview? XBMC Oral Health 2008, 8:27 http://www.biomedcentral.com/1472-6831/8/27
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the care of individual patients would be difficult. All
patients vary with regard to their pathology and clinical
characteristics and need a personalized approach to care.
Although the overall outcomes of TMJ surgery in clinical
trials may not be different than non-surgical care, TMJ sur-
gery may still be the best option for specific patients and
should be a treatment that should not be forgotten.
The most troubling aspect of our findings involves the
ethics of trials that do not meet international standards of
conduct, and the care of patients that is not based on high
levels of evidence. The potential implications of this fail-
ing is clearest to understand in terms of the U.S. Supreme
Court ruling in Daubert v. Merrell Dow[42]. In this case
the Supreme Court applied the Federal Rules of Evi-
dence[43] for causality of harm, based on the highest level
of evidence. This ruling supplanted the common-law test
of Frye v. United States, which based rulings on local prac-
tice customs. Thus one might imagine that legal suits
could arise from the application of trial methodology or
clinical practice that does not meet international stand-
ards.
Conclusion
We identified two systematic reviews that compared surgi-
cal and non-surgical treatment of TMJD. Both studies
indicated that there are no statistically significant differ-
ences between the effects of the identified treatments.
However, both studies, while of different methodological
quality, could only identify, and thus based their out-
comes on studies of mixed quality. This raises 2 concerns.
First, we are basing clinical care on studies of low quality
and second there is a clear need for considerably more
attention to clinical trial design, implementation and
reporting, if one is to provide quality patient care.
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1. Did the review ask a clearly-focused question? X
2. Did the review include the right type of study? X
3. Did the reviewers try to identify all relevant studies? X
4. Did the reviewers assess the quality of the included studies? X
5. If the results of the studies have been combined, was it reasonable to do so? X
6. The main results are presented? X
7. Are these results precise? X
8. Can the results be applied to the local population? X
9. Were all important outcomes considered? X
10. Should policy or practice change as a result of the evidence contained in this review? X
Table 9: Quality of the Reviews
Instrument Kropmans et al 1999[27] Reston and Turkelson 2003[28]
YES CAN'T TELL NO TOTAL YES CAN'T TELL NO TOTAL
n%n %n % n% n%n %n % n%
AMSTAR 2 18.2 2 18.2 7 63.6 11 100.0 7 63.6 4 36.4 0 0.0 11 100.0
OQAQ 2 22.2 4 44.4 3 33.3 9 100.0 8 88.9 0 0.0 1 11.1 9 100.0
CASP 3 30.0 5 50.0 2 20.0 10 100.0 8 80.0 2 20.0 0 0.0 10 100.0
Mean 23.5 77.5
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